https://news.sky.com/story/electric-hea ... l-13150095
But the paper says...
https://www.scirp.org/journal/paperinfo ... rid=133103
This is just ludicrous - it would have been so straightforward to have a control version of the device that did not deliver tDCSOpen-label patient cohort design with no control group. Thirty-one adult patients completed six weeks of Flow treatment.